This company seems to have been delisted
Reason: Merged with Viewpoint Molecular
Last recorded trade on: April 21, 2023
Source: https://isoray.com/2023/02/isoray-completes-merger-with-viewpoint-molecular-targeting-to-advance-new-treatment-paradigm-in-targeted-precision-oncology-medicine/
Reason: Merged with Viewpoint Molecular
Last recorded trade on: April 21, 2023
Source: https://isoray.com/2023/02/isoray-completes-merger-with-viewpoint-molecular-targeting-to-advance-new-treatment-paradigm-in-targeted-precision-oncology-medicine/
Isoray
ISR
£0.30
Share price
0.00%
Change (1 day)
34.43%
Change (1 year)
Categories
Isoray (ISR) - Total debt
Total debt on the balance sheet as of December 2022 : £0.3 Million
According to Isoray 's latest financial reports the company's total debt is £0.3 Million. A company’s total debt is the sum of all current and non-current debts.
Isoray - Total debt on balance sheet (from 1999 to 2022)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-06-30 | £0.43 M | -22.95% |
| 2021-06-30 | £0.56 M | -31.33% |
| 2020-06-30 | £0.81 M | |
| 2010-06-30 | £0.12 M | -41.23% |
| 2009-06-30 | £0.2 M | -6.1% |
| 2008-06-30 | £0.21 M | -45.24% |
| 2007-06-30 | £0.39 M | -50.61% |
| 2006-06-30 | £0.8 M | |
| 1999-09-30 | N/A | -100% |
| 1998-09-30 | £0.09 M | -57.46% |
| 1997-09-30 | £0.23 M | -36.59% |
| 1996-09-30 | £0.36 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 | £0.16 B | 54,361.73% | 🇺🇸 USA |
 | £3.84 M | 1,165.31% | 🇺🇸 USA |
 | £1.97 B | 647,961.22% | 🇺🇸 USA |
 | £14.94 B | 4,916,481.63% | 🇺🇸 USA |